Hemangiopericytomas of the spine: case report and review of the literature by Cole, Chad D & Schmidt, Meic H
[page 132] [Rare Tumors 2009; 1:e43]
Hemangiopericytomas of the
spine: case report and review
of the literature
Chad D. Cole
1 Meic H. Schmidt
1,2
1Department of Neurological Surgery,
University of Utah, Salt Lake City, Utah;
2Spinal Oncology Service, Huntsman
Cancer Institute, University of Utah, Salt
Lake City, Utah
Abstract 
We  describe  a  rare  case  of  a  primary
intracranial  meningeal  hemangiopericytoma
(HPC)  with  late  metastasis  to  the  cervical
spine. A 36-year-old woman had a left occipital
lesion that was histopathologically identified
as  HPC.  Fourteen  years  after  resection,  the
tumor  recurred  and  was  treated  with  radio-
therapy. Three years later, CT imaging showed
a  large  mass  in  the  liver  consistent  with
metastatic HPC, and MRI of the cervical spine
showed an extensive lesion of the C3 vertebral
body.  The  patient  underwent  C3  corpectomy
with en-bloc tumor removal and follow-up radi-
ation with no local recurrence or other spinal
metastasis  for  the  following  4  years.
Regardless of the subtype of spinal HPC, com-
plete surgical removal and radiotherapy appear
to be treatment of choice. 
Introduction
The  term  “hemangiopericytoma”  (HPC)  is
used to describe a wide variety of lesions shar-
ing  certain  morphological  characteristics:  a
monotonous appearance at low-power examina-
tion, moderate to high cellularity, and numer-
ous, variably thick-walled, branching ‘staghorn’
vessels.
1 HPCs  demonstrating  obvious  malig-
nant  features  generally  behave  aggressively;
however, a small proportion of benign-looking
lesions can recur and even metastasize.
1
Meningeal  HPCs  (M-HPCs)  have  different
light microscopic, ultrastructural, and immuno-
histochemical features than meningiomas and
are  not  considered  variants  of  meningiomas.
Their clinical behavior is more aggressive than
that of benign meningiomas, and they have a
strong  tendency  for  local  recurrence  and
extracranial metastasis.
2-4 
Spinal HPCs are significantly less common
than  intracranial  M-HPCs.  Despite  the  well-
known but rare occurrence of HPC within the
vertebral column, its natural history and man-
agement  remain  somewhat  elusive.  We
describe a patient with primary intracranial M-
HPC  with  cervical  spinal  metastasis  that
occurred six years after the primary lesion was
detected.  We  also  reviewed  the  literature  to
identify HPCs affecting the spine and to identi-
fy recognized treatment options. 
Case Report
A 36-year-old woman visited the emergency
room after experiencing several years of visu-
al disturbances of increasing severity and fre-
quency, nausea, dizziness, imbalance, hyper-
ventilation, and numbness and upper extremi-
ty tingling. Imaging indicated that she had a
left occipital lesion that enhanced on adminis-
tration of a contrast agent. A complete resec-
tion  was  performed,  and  her  symptoms
improved. Pathological analysis of the resec-
tion was consistent with a meningioma.
The patient did well for fourteen years but
redeveloped visual and neurological symptoms
and was found to have local recurrence of the
lesion. At this time, histopathological analysis
showed the lesion to be HPC. Re-review of the
pathological  analysis  done  of  the  original
lesion demonstrated that the tumor was a HPC
that had been misdiagnosed as a meningioma.
The patient underwent a course of radiothera-
py to the left tentorium cerebellar region at a
dose of 5400 cGy. Three years later, she devel-
oped  right  upper  abdominal  pain  syndrome,
and a computed tomography (CT) scan showed
a large mass that filled the right lobe of the
liver. She underwent a biopsy and a right hepa-
tectomy, and the tissue was found to be consis-
tent  with  metastatic  HPC.  Along  with  the
metastasis in the liver, a lesion at the C3 ver-
tebral body was found (Figure 1). On follow-up
clinical evaluation, the patient had mild neck
pain, with no motor deficits or sensory deficits. 
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Figure 1. A. Preoperative axial CT scan of
C3. Note the destructive process involving
the vertebral body. B. Preoperative coronal
CT scan of C3.
A
B
Figure  2.  Preoperative  T2-weighted  axial
MR image of C3. The hyperintense lesion
is noted anterior to the spinal canal within
the vertebral body of C3 adjacent to the
left vertebral artery.[Rare Tumors 2009; 1:e43] [page 133]
Magnetic resonance imaging (MRI) of the
cervical spine showed an extensive lesion of
the C3 vertebral body that occupied approxi-
mately 90% of that vertebral body. It was direct-
ly adjacent to both vertebral arteries, and there
was no evidence of epidural extension (Figure
2).  An  attempt  was  made  to  embolize  the
tumor, which had high vascularity, but the pro-
cedure  was  unsuccessful  because  there  was
significant  arterial  supply  to  the  anterior
spinal artery. None of the branches were large
enough to be accessed safely for embolization.
Two months later, the patient underwent a C3
corpectomy with removal of the tumor en bloc.
To reconstruct the vertebral body, a titanium
mesh cage, polymethylmethacrylate (PMMA),
and  an  anterior  cervical  plate  were  used
(Figure 3).
7 Follow-up radiation treatment of
Case Report
Figure 3. Postoperative sagittal CT of the
cervical spine. A corpectomy of the verte-
bral  body  has  been  performed  with  the
placement  of  a  titanium  mesh  cage,
PMMA, and an anterior cervical plate.
Figure 4. Postoperative T2-weighted sagit-
tal MR image of the cervical spine. A cor-
pectomy  of  the  vertebral  body  has  been
performed, and the C3 vertebral body is
distorted by the placement of a titanium
mesh cage, PMMA, and an anterior cervi-
cal plate.
Table 1. Reported cases of spinal HPC.
Study Age Level Treatment Follow-up Outcome
(yrs)/Sex period
Extradural
Schirger et al. 33/F T2  Surgery 1 yr Recurrence
1958
43
Krisset al.  16/M C6-C7 Surgery, RT 9 No symptoms of
1968
20 months recurrence
Fathie  21/M T6 Surgery –  –
1970
19
Pitkethly et al. 6 spinal tumors reported, no additional information
1970
36
McMaster et al. – T1,T2 Surgery ––
1975
44 – T6,T7 Surgery ––
– T10 Surgery ––
– T11 Surgery ––
– S1 Surgery ––
Stern et al. 31/F C6 Surgery 1 yr Tumor free
1980
45
Muraszko et al. 41/F L2 Surgery ––
1982
21 15/M T12 RT then surgery ––
11/F T11 Surgery, RT 6 yrs Recurrence at 3
yrs, surgery/RT 
recurrence at 6 yrs
Bridges et al. 25/M  S1  Surgery, RT 9 Tumor free
1988
46 months
Cappabianca et al. 52/F C6 Surgery 1 Died (unknown
1981
17 36/F C5 Surgery month cause)
2 yrs Died (unknown
cause)
Ciappetta et al. 48/M C4 Surgery 7 yrs Recurrence at 6 yrs
1985
18
Ijiri et al.  39/F L1-L2 Surgery 2 yrs Tumor free
2002
47
Akhaddar et al. 39/M Thoracic Surgery, RT  – Tumor-free
2002
48
Mohammadianpanah 21/M T2 Surgery, RT  –  –
et al. 2004
49
Primary osseous
Gerner et al.  62/M  L5  Surgery, RT  –  –
1974
50
Wold et al.  47/F Sacrum Surgery, RT  1.5 yrs Died (unknown
1982
51 62/F Sacrum –– cause)
33/F Vertebra Surgery 31 yrs Died (unknown
37/F Sacrum Surgery, RT 5 yrs cause)
Died (unknown
cause)
Died (unknown
cause)
Tang et al.  19/M L2 Chemotherapy, 4 yrs Local recurrence
1988
24 RT, surgery after 3 years,
treated with
chemotherapy,
persistent growth
1 yr later
RT, radiation therapy; –, not available.[page 134] [Rare Tumors 2009; 1:e43]
the  cervical  spine  was  administered  with  a
total dose of 3750 cGy in 15 fractionated doses
over 21 days. Clinical and imaging monitoring
during the past four years has demonstrated
no local recurrence or other spinal metastasis
(Figure 4). 
Discussion
HPCs  are  soft  tissue  tumors  composed  of
capillary blood vessels with one or more layers
of rounded cells showing features of pericytic
differentiation.  The  thick-walled,  branching
‘staghorn’  vessels  are  easily  identified.
Pericytic differentiation, which is more diffi-
cult to diagnose, has been based historically on
the presence of elongated cell processes, peri-
cellular basal lamina, plasmalemmal pinocyto-
sis, and variable numbers of microfilaments.
8
Immunohistochemical analysis has shown that
these tumors usually express muscle-specific
actin, smooth muscle actin, and tropomyosin
but  are  mostly  negative  for  desmin  and  h-
caldesmon.
9,10
The  clinical  behavior  of  HPCs,  especially
extrapleural  HPCs,  is  unpredictable.
Approximately  10%  to  15%  of  these  tumors
demonstrate malignant behavior in the form of
recurrent  or  metastatic  disease.
11,12 Systemic
metastases from intracranial HPCs have been
reported.  The  specific  criteria  that  define
malignancy for HPCs include large tumor size
(>50 mm), disseminated disease at presenta-
tion,  infiltrative  margins,  high  cellularity,
nuclear pleomorphism, areas of tumor necro-
sis,  and  an  increased  mitotic  index  (>4
mitoses  per  10x  high-powered  field).
11-14
Nevertheless,  the  correlation  between  mor-
phology and outcome is poor: some histologi-
cally  malignant-looking  lesions  may  behave
benignly, and some morphologically innocuous
lesions behave aggressively.
1,11,13,15
Cases of spinal HPC are much less common
than  cases  involving  other  anatomical  loca-
tions. Intraspinal extradural M-HPCs and pri-
mary osseous HPCs are difficult to differenti-
ate  but  are  more  frequent  than  intradural
HPCs and secondary osseous HPCs. Thirty-one
cases of extradural and primary osseous spinal
HPC have been reported within the English lit-
erature  (Table  1).  HPCs  of  intracranial  or
extracranial primary sites that metastasize to
the  spine  (Table  2)  are  much  rarer.
5,6,16
Intradural spinal HPCs (Table 3) are as rare as
these latter two spinal HPC subtypes. 
We have separated extradural (intraspinal)
from primary osseous HPCs according to their
original  case  reports,  although  delineating
them is often difficult. In reviewing the litera-
ture, we found that different clinical features
have been observed in extradural M-HPC and
primary osseous HPC. Extradural HPCs gener-
ally involve the middle and lower portions of
the cervical spine. Often, but not always, these
tumors  demonstrate  a  dural  attachment.
17-21
Because  of  the  involvement  of  the  epidural
space, radiculomyelopathy is a common find-
ing.
22,23 In contrast, primary osseous HPCs of
the spine mostly affect the lumbosacral spine
and have paravertebral extension 
24 but do not
result in neurological deficit. The most com-
mon complaints are pain and mass effect.
24
Spinal  metastasis  should  be  considered  a
possibility when a patient who has been treat-
ed previously for HPC presents with back or
neck pain or pain accompanied by weakness.
25
Once symptomatic spinal metastasis is diag-
nosed,  there  is  no  satisfactory  treatment
modality  to  stop  the  fast  and  fatal  progres-
sion.
25 Bone  scintigraphy  may  be  a  useful
screening  tool  to  detect  osseous  metastasis
early; however, a single negative scan may not
be sufficient to confirm that there has been no
bony  metastasis.
26 In  addition,  gadolinium-
enhanced  MRI  provides  a  very  sensitive
method  of  detecting  spinal  metastasis.  For
those patients who survive more than several
Case Report
Table 2. Reported cases of metastatic HPC to the spine.
Study Age Time until Location of Location Treatment Outcome
(yrs) metastasis primary of
/Sex (yrs) tumor metastasis
Cranial meningeal
Kruse 22/F 8  Frontoparietal Lumbar Surgery –
1961
52 vertebra
Scott et al. 38/M 16  Posterior T12/L1 Surgery, RT Improvement 
1974
53 cranial fossa but death
after
complication
Nonaka et al. 40/F 9.5 Tentorium T8 Surgery, RT Good
1998
26 recovery
Woitzik et al. 40/F  8 Frontal C6-T2 Surgery, RT Good
2003
16 recovery
9 L2 RT Not stated
Lee et al. 48/F 6.5 Middle cranial C6-C7 Surgery, RT Improvement
2006
25 fossa
Taniura et al.  30/F 4 Posterior L4-S1 Surgery, RT  Improvement
2007
54 cranial fossa
Present 36/F 17 Posterior C3 Surgery, RT Good
case cranial fossa recovery
Extracranial locations
Mao and 56/M –  Heart; –  Surgery, RT Death due to
Angrist spine: L3 cardiac arrest
1967
55
Herrmann  68/F 2 Right arm T8 Surgery Gradual
et al. (subtotal), RT improvement
1968
56 of paraparesis
Harris et al. 46/M 4  Groin; lung 3 C5 Surgery, RT, Neurological
1978
57 years later chemotherapy deterioration
Hansen  et al. 50/M 17 months Lung L3 RT ‘Relief of
1990
58 symptoms,’
patient
refused
further
treatment
Brass et al. 48/M 5 Lower T2-3 Partial 1 yr
2004
59 cervical and resection, RT recurrence, at
upper 2 yrs
thoracic complete
musculature sensory-motor
paralysis at
T4 level
RT, radiation therapy; –, not available.[Rare Tumors 2009; 1:e43] [page 135]
years after the diagnosis of their primary HPC,
aggressive spinal surveillance should be advo-
cated.
25
Several long-term studies have documented
the propensity of M-HPCs to recur locally or
regionally  within  the  cranial  or  spinal
meninges.
2,27-36 Results from the literature sug-
gest that complete excision is more successful
in preventing or delaying recurrence than is
incomplete  excision.
2,27,31,34,37,38 Complete  exci-
sion at the first operation significantly extend-
ed  the  average  time  before  first  recurrence
from 43 months to 111 months. The five-year
recurrence-free rate for those patients treated
with  complete  excision  was  72.7%,  whereas
that for those patients treated with incomplete
excision was just 20.8%. 
The surgeon should be prepared for a sub-
stantial amount of bleeding during tumor exci-
sion because of the high vascularity of HPCs.
16
This bleeding can lead to high surgery-related
morbidity and mortality and can be the great-
est  hindrance  to  gross  total  resection.
Preoperative  embolization  can  be  used  to
reduce blood loss. Thus, en bloc resection with
extratumoral  devascularization  is  the  option
most likely to reduce operative blood loss and
possibly decrease the risk of recurrence; how-
ever, this may not be possible for those tumors
with extensive premedullary portions.
16 When
considering  resection  options,  the  surgeon
should  also  be  mindful  that  a  piecemeal
removal  is  associated  with  an  earlier  recur-
rence rate.
5
Even after en bloc resection, the possibility
of recurrence necessitates close monitoring of
the patient and consideration of adjuvant ther-
apy. The length of survival for each patient also
depends on the site and size of the primary
tumor.
39 Tumors larger than 6 cm are associat-
ed with much poorer prognosis than are small-
er  tumors.
14 Outcomes  for  patients  with
intradural  and  extradural  HPCs  have  been
found  to  be  similar.  Even  with  the  similar
recurrence  rates,  however,  disease-free  sur-
vival  was  longer  for  those  patients  with  an
intradural  lesion  (average  of  6  years  before
recurrence).
5
Although surgery alone offers local control
of  several  years  on  average,  the  addition  of
postoperative  radiotherapy  (RT)  to  surgical
treatment  appears  to  be  the  best  long-term
treatment option for HPCs.
32 Using intensity-
modulated RT and fractionated stereotactic RT
with high radiation doses, the morbidity asso-
ciated with adjacent organ damage, especially
spinal cord toxicity, is minimized.
40,41 Combs et
al.
40 analyzed the use of high-precision RT in
patients  with  HPC,  including  2  spine  cases.
They demonstrated an overall survival rate of
100%  at  5  years  and  64%  at  10  years  for
patients treated with a combination of surgical
and RT approaches. 
Radiosurgery  and  intensity-modulated  RT
can be considered in the setting of prior radia-
tion,  although  the  role  of  radiosurgery  for
metastatic spine disease is evolving because
new  technologies  that  deliver  higher,  more
conformal  doses  of  radiation  could  result  in
better local control.
42 The use of chemotherapy
remains controversial, as most attempts have
been disappointing. 
Conclusions
Intradural,  intraspinal  extradural  menin  -
geal/primary osseous, and secondary metastat-
ic osseous HPCs in the spine are rare and have
only been infrequently reported. Regardless of
the subtype, complete surgical removal and RT
appear to be treatment of choice for HPC in the
spine.  Overall  and  progression-free  survival
times of patients with HPCs have continuously
improved; however, the treatment of HPC is
still unsatisfactory and remains a great chal-
lenge.
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